{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:09:46Z","timestamp":1793196586867,"version":"4.5.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s40265-024-02057-w","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T05:01:31Z","timestamp":1719291691000},"page":"863-866","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Zastaprazan: First Approval"],"prefix":"10.1007","volume":"84","author":[{"given":"Hannah A.","family":"Blair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"4","key":"2057_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.cgh.2019.07.015","volume":"18","author":"DA Katzka","year":"2020","unstructured":"Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal meet. Clin Gastroenterol Hepatol. 2020;18(4):767\u201376.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2057_CR2","first-page":"295","volume":"19","author":"D Armstrong","year":"2023","unstructured":"Armstrong D. Potassium-competitive acid blockers and gastroesophageal reflux disease. Gastroenterol Hepatol. 2023;19(5):295\u20138.","journal-title":"Gastroenterol Hepatol"},{"key":"2057_CR3","unstructured":"Onconic Therapeutics. Onconic Therapeutics receives MFDS approval for JAQBO, a new treatment for gastroesophageal reflux disease (GERD) [media release]. 25 Apr 2024. https:\/\/www.prnewswire.com\/in\/news-releases\/onconic-therapeutics-receives-mfds-approval-for-jaqbo-a-new-treatment-for-gastroesophageal-reflux-disease-gerd-302127478.html."},{"key":"2057_CR4","unstructured":"Onconic Therapeutics. JAQBO 20 mg tablets (zastaprazan citrate): Korean prescribing information. 2024."},{"key":"2057_CR5","unstructured":"Livzon Pharmaceuticals. Voluntary announcement entering into the license agreement [media release]. 10 Mar 2023. http:\/\/www1.hkexnews.hk."},{"issue":"3","key":"2057_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1090","volume":"11","author":"JM Ku","year":"2023","unstructured":"Ku JM, Cho JH, Kim K, et al. JP-1366: a novel and potent potassium-competitive acid blocker that is effective in the treatment of acid-related diseases. Pharmacol Res Perspect. 2023;11(3): e01090.","journal-title":"Pharmacol Res Perspect"},{"issue":"7","key":"2057_CR7","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/apt.17406","volume":"57","author":"I Hwang","year":"2023","unstructured":"Hwang I, Ji SC, Oh J, et al. Randomised clinical trial: safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects. Aliment Pharmacol Ther. 2023;57(7):763\u201372.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 8","key":"2057_CR8","first-page":"54","volume":"11","author":"J Oh","year":"2023","unstructured":"Oh J, Kim H, Cheung DY, et al. Randomised, double-blind, active-controlled phase 3 study to evaluate the efficacy and safety of zastaprazan compared with esomeprazole in erosive oesophagitis [zastaprazan erosive reflux oesophagitis-1 study (ZERO-1)] [abstract no. OP050]. United Eur Gastroenterol J. 2023;11(Suppl 8):54\u20136.","journal-title":"United Eur Gastroenterol J"}],"updated-by":[{"DOI":"10.1007\/s40265-024-02093-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000}}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-024-02057-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-024-02057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T16:14:30Z","timestamp":1728576870000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-024-02057-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1007\/s40265-024-02057-w","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"30 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40265-024-02093-6","URL":"https:\/\/doi.org\/10.1007\/s40265-024-02093-6","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"During the peer review process, the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Hannah A. Blair is a salaried employee of Adis International Ltd\/Springer Nature, and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship and Conflict of Interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval, Consent to Participate, Consent to Publish, Availability of Data and Material, Code Availability"}}]}}